0
From the Centers for Disease Control and Prevention |

Outbreak of Botulism Type E Associated With Eating a Beached Whale—Western Alaska, July 2002 FREE

JAMA. 2003;289(7):836-838. doi:10.1001/jama.289.7.836.
Text Size: A A A
Published online

MMWR. 2003;52:24-26

One figure, one table omitted

Botulism is a neuroparalytic illness caused by toxins produced by the bacterium Clostridium botulinum, an obligate anaerobe found commonly in the environment. Intoxication with toxin type E is associated exclusively with eating animal foods of marine (salt or fresh water) origin. Persons who eat raw or fermented marine fish and mammals are at high risk for botulism from type E toxin. On July 17, 2002, the Alaska Division of Public Health investigated a cluster of suspected botulism cases among residents of a fishing village in Alaska. This report summarizes the findings of the outbreak investigation, which linked disease to eating raw muktuk (skin and a pink blubber layer) from a beached whale. To avoid delays in treatment, health-care providers evaluating patients suspected of having botulism should base treatment decisions on clinical findings. Public health authorities should be notified immediately about any suspected botulism case.

During July 13-15, residents of a western Alaska village on the Bering Sea shore shared a meal consisting of muktuk harvested from a beached adult beluga whale found near their village. The villagers estimated that the whale had been dead for at least several weeks. They cut the whale fluke (tail) into pieces and stored them in zipper-sealed plastic bags in a refrigerator until they were eaten 1 or 2 days later. On July 17, after a physician from western Alaska reported three suspected cases of botulism among patients who had eaten the muktuk, the Alaska Section of Epidemiology began an investigation.

A case of foodborne botulism was defined as illness in a person who had eaten the muktuk and subsequently had symmetric descending flaccid paralysis of motor and autonomic nerves. Persons who ate muktuk were interviewed and examined, and their hospital records were reviewed. Serum, stool, and gastric contents from patients and leftover blubber were tested for botulinum toxin.

Of 14 persons identified who ate the muktuk, eight (57%) had an illness that met the case definition. Five of the eight patients were female; the median age was 73 years (range: 13-83 years). Symptom onset after ingestion of muktuk occurred within 36 hours in all patients. Five patients were hospitalized, four received antitoxin, and two required mechanical ventilation. Three stool, three gastric fluid, and seven serum samples from the eight patients and seven samples of muktuk were tested for botulinum toxin at CDC's National Botulism Surveillance and Reference Laboratory. The diagnostic laboratory received all laboratory specimens on July 26, and results were reported on August 1. Type E toxin was detected in stool from one patient. All seven samples of muktuk were positive for type E botulinum toxin.

Reported by:

J Middaugh, MD, T Lynn, DVM, B Funk, MD, B Jilly, PhD, Div of Public Health, Alaska Dept of Health and Social Svcs. Div of Bacterial and Mycotic Diseases, National Center for Infectious Diseases; S Maslanka, PhD, Div of Applied Public Health Training, Epidemiology Program Office; J McLaughlin, MD, EIS Officer, CDC.

CDC Editorial Note:

This report summarizes a foodborne outbreak of botulism in a western Alaska village that resulted from residents eating muktuk contaminated with type E botulinum toxin. During 1973-1998, a total of 814 cases and an annual median of 24 cases (range: 14-94 cases) of foodborne botulism were reported to CDC1; 236 (29%) of these cases occurred in Alaska (CDC, unpublished data, 2003). Although botulism is a rare disease, its presentation is distinctive (Box). Because of the epidemic potential of foodborne botulism, every case should be reported and investigated immediately.

All patients suspected of having foodborne botulism should be placed in an intensive care setting, monitored regularly for respiratory function deterioration, and provided mechanical ventilation if necessary. Prompt administration of polyvalent equine-source antitoxin can decrease the progression of paralysis and severity of illness but will not reverse existing paralysis. Botulinum antitoxin is available in the United States only through the public health system. Therefore, rapid clinical diagnosis, notification of public health authorities, and timely administration of antitoxin are imperative.2 Laboratory confirmation of botulinum intoxication cannot be relied on in making treatment decisions because the standard test, the mouse bioassay, requires approximately 4 days for final results.2 In addition, the sensitivity of laboratory testing of clinical samples is low.3,4 In this outbreak, typed toxin was detected in only 8% of samples from patients who had definitive exposure to contaminated muktuk.

The probable mode of contamination of the whale in this outbreak was either growth and toxin secretion by C. botulinum present in the intestinal tract of the whale or traumatic introduction of C. botulinum spores into the beached whale tissue from contact with sand, rocks, and driftwood, and subsequent germination and toxin production. C. botulinum type E has been found in Alaska coastline soil,5 and outbreaks of botulism associated with eating beached marine mammals are documented (Alaska Section of Epidemiology, unpublished data, 2003). A previous report on the accumulation of C. botulinum toxins in the North Sea coastal food chain associated with beached whales suggested the disposal of the carcasses as a preventive measure.6 However, because of the impracticality of frequent scanning of the vast Alaska shoreline and high costs associated with disposal, the U.S. Fish and Wildlife Service does not remove beached mammal carcasses regularly.

Because of the epidemic potential of foodborne botulism and the status of botulinum toxins as a category A agent of terrorism, health-care providers should be familiar with the presentation of botulism. Treatment is based on clinical diagnosis, and rapid recognition and reporting of cases are the cornerstones of successful public health interventions to prevent additional illnesses. Persons should avoid eating beached marine mammal carcasses and boil raw or fermented Alaska Native dishes ≥10 minutes before eating to inactivate botulinum toxin. Additional information on botulism prevention is available at http://www.phppo.cdc.gov/phtn/botulism/alaska/alaska.asp and http://www.epi.hss.state.ak.us/pubs/botulism/bot_01.htm.

BOX. Epidemiology, diagnosis, treatment, and prevention of foodborne botulism

Epidemiology

  • • Caused by eating foods contaminated with preformed toxins of Clostridium botulinum

  • Home-canned foods and raw or fermented Alaska Native dishes commonly associated with illness

  • During 1973–1998, a total of 814 cases and an annual median of 24 cases (range: 14–94 cases) of foodborne botulism reported in the United States; 236 (29%) in Alaska

  • Humans affected by toxin types A, B, E, and rarely F; type E intoxication associated exclusively with eating marine animals

  • Classified as a category A terrorism agent

Clinical findings

  • • Cranial nerve palsies

  • Symmetrically descending flaccid voluntary muscle weakness possibly progressing to respiratory compromise

  • Normal body temperature

  • Normal sensory nerve examination findings

  • Intact mental status despite groggy appearance

  • Differential diagnosis includes Guillain-Barré syndrome, myasthenia gravis, stroke, drug overdose, and other entities

Laboratory findings

  • Normal cerebrospinal fluid values • Specific electromyography (EMG) findings including — normal motor conduction velocities — normal sensory nerve amplitudes and latencies — decreased evoked muscle action potential — facilitation following rapid repetitive nerve stimulation

  • Standard mouse bioassay positive for toxin from clinical specimens and/or suspect food; requires up to 4 days for final results

Recommended treatment

  • Prompt administration of polyvalent equine-source antitoxin — can decrease the progression of paralysis and severity of illness — will not reverse existing paralysis — available in the United States only through the public health system

  • Place suspect cases in an intensive care setting

  • Monitor for respiratory function deterioration every 4 hours using forced vital capacity testing

  • Provide mechanical ventilation if necessary

Prevention and control

  • Boil raw or fermented Alaska Native dishes and homecanned foods >10 minutes before eating

  • Follow recommended home-canning procedures

  • Notify state health department immediately of suspected cases

References
Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review.  Ann Intern Med.1998;129:221-8.
Arnon SS, Schechter R, Inglesby TV.  et al.  Botulinum toxin as a biological weapon: medical and public health management. Available at http://jama.ama-assn.org/issues/v285n8/ffull/jst00017.html#a6.
Woodruff BA, Griffin PM, McCroskey LM.  et al.  Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988.  J Infect Dis.1992;166:1281-6.
Dowell Jr VR, McCroskey LM, Hatheway CL.  et al.  Coproexamination for botulinal toxin and clostridium botulinum: a new procedure for laboratory diagnosis of botulism.  JAMA.1977;238:1829-32.
Miller LG. Observations on the distribution and ecology of Clostridium botulinum type E in Alaska.  Can J Microbiol.1975;21:920-6.
Stede M. Problems of disposal of dead marine mammals. Dtsch Tierarztl Wochenschr 1997;104:245-7.

Figures

Tables

References

Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review.  Ann Intern Med.1998;129:221-8.
Arnon SS, Schechter R, Inglesby TV.  et al.  Botulinum toxin as a biological weapon: medical and public health management. Available at http://jama.ama-assn.org/issues/v285n8/ffull/jst00017.html#a6.
Woodruff BA, Griffin PM, McCroskey LM.  et al.  Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988.  J Infect Dis.1992;166:1281-6.
Dowell Jr VR, McCroskey LM, Hatheway CL.  et al.  Coproexamination for botulinal toxin and clostridium botulinum: a new procedure for laboratory diagnosis of botulism.  JAMA.1977;238:1829-32.
Miller LG. Observations on the distribution and ecology of Clostridium botulinum type E in Alaska.  Can J Microbiol.1975;21:920-6.
Stede M. Problems of disposal of dead marine mammals. Dtsch Tierarztl Wochenschr 1997;104:245-7.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles